Assessment of prognostic factors in previously treated Japanese patients with metastatic renal cell carcinoma who received nivolumab: An observational multi‑institute study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of prognostic factors in previously treated Japanese patients with metastatic renal cell carcinoma who received nivolumab: An observational multi‑institute study

Published:2021-11-21 Issue:1 Volume:16 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Ito Toshiki¹,Mizutani Kosuke²,Takahara Kiyoshi³,Ando Ryosuke⁴,Yasui Takahiro⁴,Shiroki Ryoichi³,Koie Takuya²,Miyake Hideaki¹

Affiliation:

1. Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431‑3192, Japan

2. Department of Urology, Gifu University Graduate School of Medicine, Gifu 501‑1194, Japan

3. Department of Urology, Fujita Health University School of Medicine, Toyoake, Aichi 470‑1192, Japan

4. Department of Nephro‑urology, Nagoya City University Graduate School of Medical Science, Nagoya, Aichi 467‑8601, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST‐NIVO study): 36‐month follow‐up results of a clinical chart review;International Journal of Urology;2023-05-29

2. Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab;Nutrition and Cancer;2022-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP